Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...
Circulating tumor DNA may be an effective biomarker for stratifying patients with small cell lung cancer who would benefit from more stringent follow-ups and clinical trial participation.Patients who ...
Alveltamig is a trispecific T-cell engager, enhancing immune response by linking T cells to cancer cells with three binding arms. The trial addresses treatment challenges for small cell lung cancer ...
Do you want to find out if you have lung cancer?Well, medical professionals have revealed that a simple “finger test” could ...
The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...
MedPage Today on MSN
Time of Day Matters for Immunochemotherapy in Lung Cancer
This is a "landmark study" for cancer immunotherapy and circadian medicine, researcher say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results